2026-02-04 14:38 |
[DKFZ-2026-00276]
Journal Article
Kottlors, J. ; Iuga, A.-I. ; Bluethgen, C. ; et al
Guidelines for Reporting Studies on Large Language Models in Radiology: An International Delphi Expert Survey.
Large language models (LLMs) have transformative potential in radiology, including textual summaries, diagnostic decision support, proofreading, and image analysis. However, the rapid increase in studies investigating these models, along with the lack of standardized LLM-specific reporting practices, affects reproducibility, reliability, and clinical applicability. [...]
Detailed record - Similar records
|
2026-02-04 14:35 |
Detailed record - Similar records
|
2026-02-04 14:28 |
Detailed record - Similar records
|
2026-02-04 14:27 |
[DKFZ-2026-00273]
Journal Article (Review Article)
Zhang, X.-W. ; Jäger, D. ; Zschäbitz, S.
Management of Advanced Renal Cell Carcinoma.
Management of advanced renal cell carcinoma (RCC) has evolved significantly in the last years. Systemic treatment of clear cell RCC, the predominant subtype, is performed with immune checkpoint inhibitors (ICIs), anti-VEGF tyrosine kinase inhibitor (TKI), HIF2α inhibitors and mTOR inhibitors.The application of ICI in early disease has raised new challenges regarding subsequent therapy strategies and management of new toxicities of immunotherapy-based combination therapies. [...]
Detailed record - Similar records
|
2026-02-04 13:42 |
Detailed record - Similar records
|
2026-02-04 13:40 |
Detailed record - Similar records
|
2026-02-04 13:39 |
Detailed record - Similar records
|
2026-02-03 14:35 |
Detailed record - Similar records
|
2026-02-03 14:32 |
[DKFZ-2026-00268]
Journal Article
Turkot, M. H. ; Yusuf, A. ; Nowicki-Osuch, K. ; et al
Feasibility and diagnostic accuracy of a capsule-sponge device for esophageal squamous neoplasia (EDEN trial).
Endoscopic screening for esophageal squamous neoplasia (ESN) is effective, but invasive and resource-intensive. We evaluated a minimally invasive capsule-sponge sampling with p53 immunohistochemistry (p53-IHC) for the early detection of ESN.In this prospective cross-sectional proof-of-concept study, participants from three predefined groups: (1) healthy controls, (2) high-risk individuals with prior head-and-neck cancer, and (3) patients with early-stage ESN scheduled for endoscopic treatment, underwent capsule-sponge sampling followed by high-definition endoscopy (reference diagnosis). [...]
Detailed record - Similar records
|
2026-02-03 14:30 |
Detailed record - Similar records
|
|
|